用照射灭活的GM-CSF基因转染的自体肿瘤疫苗(GVAX)和CTLA-4单抗3mg/kg先后注射,共治疗了4例接受过DC疫苗治疗的IV 期黑色素瘤患者,14例接受过GVAX治疗的IV 期黑色素瘤患者,发现黑...
基于24个网页-相关网页
The trial was successful, and now the vaccine, called GVAX, has begun a final-stage trial on 600 patients at biotech firm Cell Genesys.
FORBES: Disease and Redemption
应用推荐
模块上移
模块下移
不移动